BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4133736)

  • 1. Letter: Human calcitonin and serum-phosphate.
    Silva OL; Becker KL; Selawry HP; Snider RH; Moore CF; Bivins LE; Shalhoub RJ
    Lancet; 1974 May; 1(7865):1055. PubMed ID: 4133736
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Human calcitonin, serum-phosphate, renal failure.
    McGeown MG
    Lancet; 1974 Apr; 1(7861):813-4. PubMed ID: 4132751
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcitonin levels in chronic renal disease.
    Silva OL; Becker KL; Shalhoub RJ; Snider RH; Bivins LE; Moore CF
    Nephron; 1977; 19(1):12-8. PubMed ID: 331128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical heterogeneity of calcitonin in renal failure.
    Lee JC; Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1977 Sep; 45(3):528-33. PubMed ID: 903401
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hemofiltration on plasma levels of parathyroid hormone and calcitonin].
    De Fremont JF; Fournier A; Gueris J; Caillens C; Coevoet B; Lambrey G; Quichaud J
    J Urol Nephrol (Paris); 1978; 84(4-5):323-8. PubMed ID: 682233
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcitonin in chronic renal failure.
    Garancini S; Ballada L; Roncari G; Gastaldi L
    Nephron; 1983; 34(4):224-7. PubMed ID: 6877457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin secretion in renal disease.
    Lee JC; Parthemore JG; Deftos LJ
    Calcif Tissue Res; 1977 May; 22 Suppl():154-7. PubMed ID: 912517
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethanol induced secretion of calcitonin in chronic renal disease.
    Kanis JA; Adams ND; Cecchettin M; Luizetto G; Gaspar S; Heynen G
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):155-61. PubMed ID: 428114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of beta-blockade on ethanol-induced secretion of calcitonin in chronic renal failure.
    Heynen G; Cecchettin M; Gaspar S; Kanis J; Franchimont P
    Calcif Tissue Res; 1977 May; 22 Suppl():137-41. PubMed ID: 562224
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that endogenous calcitonin protects against renal bone disease.
    Kanis JA; Oliver D; Ledingham JC; Russell RG
    Lancet; 1976 Dec; 2(7999):1322-6. PubMed ID: 63802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parathyrin and calcitonin in patients with chronic renal insufficiency].
    Dzhavad-Zade MD; Agaev MM; Karaev ME
    Med Radiol (Mosk); 1985 Dec; 30(12):47-9. PubMed ID: 4079692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum calcitonin in patients with chronic renal disease.
    Nielsen HE; Christensen CK; Olsen KJ
    Acta Med Scand; 1979; 205(7):615-8. PubMed ID: 474191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma calcitonin in chronic renal failure: relation to other factors of importance in bivalent ion metabolism.
    Shainkin-Kestenbaum R; Lerman R; Reuben A; Berlyne GM
    Clin Sci Mol Med; 1977 Jun; 52(6):577-83. PubMed ID: 328218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum gastrin and serum calcitonin in patients with chronic renal failure.
    Christensen CK; Nielsen HE; Kamstrup O; Olsen KJ; Brandsborg M; Brandsborg O
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):564-70. PubMed ID: 474043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Human calcitonin and serum-phosphate.
    Heynen G; Franchimont P
    Lancet; 1974 Apr; 1(7858):627. PubMed ID: 4132290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship between gastric acid secretion and plasma calcium, parathormone and calcitonin levels in patients with chronic renal failure on haemodialysis (author's transl)].
    Beaugrand M; Cassan P; Dongradi G; Khazine F; Fendler JP
    Nouv Presse Med; 1978 Sep; 7(30):2635-6. PubMed ID: 693300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-RowiƄska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
    Takamoto S; Onishi T; Morimoto S; Imanaka S; Tsuchiya H; Seino Y; Yokokawa T; Iida N; Kumahara Y
    Nephron; 1985; 40(3):286-91. PubMed ID: 3839293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.